Prestige Consumer's First Quarter Exclusively In OTCs Is Prelude To Growth

02 Nov 2018
News

Eileen Francis eileen.francis@informa.com

Executive Summary

Prestige Consumer's sales in its latest quarter were lifted by gas relief and ear wax products, but the gains were offset "revenue recognition" accounting changes and slower sales of BC and Goody's as supplies of the analgesics transitioned to new packaging.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

United States

Industries
Consumer

Related Companies

Prestige Consumer Healthcare Inc.

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Commercial Advertising, Marketing & Sales United States

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS124192

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS124192

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Prestige Consumer's First Quarter Exclusively In OTCs Is Prelude To Growth

News

Executive Summary

Related Content

Prestige's Monistat, Summer's Eve Brands Key Drivers In Consumer Health Focus

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert